Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery

Anaesthesia

Volumn 64, Issue 8, 2009, Pages 871-877

  Choi, Y S ^a   Kwak, Y L ^a   Kim, J C ^a   Chun, D H ^a   Hong, S W ^a   Shim, Jae Kwang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; LIOTHYRONINE; PLACEBO; THYROTROPIN; THYROXINE;

ANESTHESIA INDUCTION; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; HEART VALVE SURGERY; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; PATIENT MONITORING; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; AGED; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EUTHYROID SICK SYNDROMES; FEMALE; HEART VALVES; HEMODYNAMICS; HORMONE REPLACEMENT THERAPY; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; THYROID HORMONES; TRIIODOTHYRONINE;

EID: 67650657835     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2009.05984.x     Document Type: Article

References (24)

1. Holland FW II, Brown PS Jr, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Annals of Thoracic Surgery 1991; 52: 46-50.
2. Batra YK, Singh B, Chavan S, Chari P, Dhaliwal RS, Ramprabu K. Effects of cardiopulmonary bypass on thyroid function. Annals of Cardiac Anaesthesia 2000; 3: 3-6.
3. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993; 87: 1435-1441
4. Bennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwinn DA. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomised, double-blind, placebo-controlled trial. Duke T3 study group. Journal of the American Medical Association 1996; 275: 687-692 (Pubitemid 26076578)
5. Novitzky D, Cooper DK, Barton CI, et al. Triiodothyronine as an inotropic agent after open heart surgery. Journal of Thoracic and Cardiovascular Surgery 1989; 98: 972-977 (Pubitemid 19282995)
6. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. New England Journal of Medicine 1995; 333: 1522-1527
7. Guden M, Akpinar B, Saggbas E, Sanisoglu I, Cakali E, Bayindir O. Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovascular and Thoracic Annals 2002; 10: 219-222 (Pubitemid 35041397)
8. Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000; 356: 529-534 (Pubitemid 30611856)
9. Sirlak M, Yazicioglu L, Inan MB, et al. Oral thyroid hormone pretreatment in left ventricular dysfunction. European Journal of Cardiothoracic Surgery 2004; 26: 720-725 (Pubitemid 39273569)
10. Magalhães AP, Gus M, Silva LB, Schaan BD. Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery. Brazilian Journal of Medical and Biological Research 2006; 39: 969-978 (Pubitemid 44111065)
11. Dupuis JY, Wang F, Nathan H, Lam M, Grimes S, Bourke M. The cardiac anesthesia risk evaluation score: a clinically useful predictor of mortality and morbidity after cardiac surgery. Anesthesiology 2001; 94: 194-204. (Pubitemid 32125906)
12. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine 2001; 344: 501-509
13. Owen PJ, Sabit R, Lazarus JH. Thyroid disease and vascular function. Thyroid 2007; 17: 519-524
14. Klemperer JD. Thyroid hormone and cardiac surgery. Thyroid 2002; 12: 517-521
15. Sabatino L, Cerillo AG, Ripoli A, Pilo A, Glauber M, Iervasi G. Is the low tri-iodothyronine state a crucial factor in determining the outcome of coronary artery bypass patients? Evidence from a clinical pilot study Journal of Endocrinology 2002; 175: 577-586
16. Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107: 708-713 (Pubitemid 36222598)
17. Mullis-Jansson SL, Argenziano M, Corwin S, et al. A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. Journal of Thoracic and Cardiovascular Surgery 1999; 17: 1128-1134
18. De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. Journal of Clinical Endocrinology and Metabolism 1999; 84: 151-164 (Pubitemid 29036694)
19. Cerillo AG, Storti S, Mariani M, et al. The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study. Clinical Chemistry and Laboratory Medicine 2005; 43: 289-293 (Pubitemid 40500589)
20. Klemperer JD, Klein IL, Ojamaa K, et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Annals of Thoracic Surgery 1996; 61: 1323-1329 (Pubitemid 26150212)
21. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116: 1725-1735
22. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252
23. Dulchavsky SA, Lucas CE, Ledgerwood AM, Grabow D, Brown TR, Bagchi N. Triiodothyronine (T3) improves cardiovascular function during hemorrhagic shock. Circulatory Shock 1993; 39: 68-73.
24. Gurll NJ, Holaday JW, Reynolds DG, Ganes E. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock. Critical Care Medicine 1987; 15: 574-581 (Pubitemid 17094095)